Designing a commercial bundle for cardiac procedures: The Percutaneous Coronary Intervention Episode Payment Model

John W Urwin1, Robert Bauer2, Jonathan Cunningham2

  • 1Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, 19104, USA; Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA, 19104, USA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, , USA.

Insights

Hawaii Medical Service Association developed a novel bundled payment for percutaneous coronary interventions (PCI EPM). This commercial model aims to improve cardiac intervention payments, unlike previous unsuccessful attempts in commercially insured populations.

Area of Science:

  • Health economics
  • Interventional cardiology
  • Healthcare policy

Background:

  • Cardiac interventions represent a substantial healthcare cost.
  • Previous bundled payment models have failed in commercially insured populations.
  • A novel commercial bundled payment, the Percutaneous Coronary Intervention Episode Payment Model (PCI EPM), was developed with HMSA in 2018.

Purpose of the Study:

  • To describe the design and features of the HMSA PCI EPM.
  • To compare the PCI EPM with existing Medicare bundled payment programs.
  • To provide insights for designing future cardiac intervention payment policies.

Main Methods:

  • Descriptive analysis of the PCI EPM's components: inclusion criteria, bundle contents, pricing, savings model, and quality metrics.
  • Comparative analysis against Medicare's Bundled Payment for Care Improvement and Cardiac Care Model.

Main Results:

  • The PCI EPM is the first commercial bundled payment specifically for percutaneous coronary interventions.
  • It incorporates site neutrality and encourages outpatient care when appropriate.
  • It features first-dollar shared savings and fewer incentivized quality metrics compared to non-commercial models.

Conclusions:

  • The PCI EPM offers a unique approach to commercial bundled payments for cardiac procedures.
  • This model's features may guide future health plans and policymakers.
  • Exploring commercial bundled payments for interventional cardiology is promising.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...